| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| H-Trp(Boc)-Oh |
1-BOC-色氨酸 |
146645-63-8 |
詳細(xì)
|
| Roxadustat Impurity 125 |
羅沙司他中間體 |
1455091-04-9 |
詳細(xì)
|
| Pantoprazole Impurity 41; Omeprazole Impurity 1 |
奧美拉唑雜質(zhì) |
|
詳細(xì)
|
| Isavuconazole Impurity 154 |
艾沙康唑雜質(zhì)154 |
150803-12-6 |
詳細(xì)
|
| Alanyl Glutamine Impurity 10 |
丙氨酰谷氨酰胺雜質(zhì)7 |
1508274-80-3 |
詳細(xì)
|
| Sirolimus Impurity 4 (7-O-Demethyl Rapamycin) |
Rapamycin, 7-O-demethyl- |
151519-50-5 |
詳細(xì)
|
| Cholic Acid Impurity 6 |
3,7-METHYLENE, 12-HYDROXY CHOLIC ACID |
15173-22-5 |
詳細(xì)
|
| Glucose Impurity 1 |
葡萄糖雜質(zhì)1 |
1518-54-3 |
詳細(xì)
|
| Desloratadine 11-Hydroxy Impurity |
氯雷他定雜質(zhì)8 |
153200-97-6 |
詳細(xì)
|
| Penehyclidine Impurity 13 |
戊乙奎醚雜質(zhì)7 |
14704-09-7 |
詳細(xì)
|
| Dapoxetine Impurity 2 |
達(dá)泊西汀雜質(zhì)1 |
147199-39-1 |
詳細(xì)
|
| Clindamycin Impurity 70 |
克林霉素雜質(zhì) |
147650-54-2 |
詳細(xì)
|
| Vandetanib Impurity 12 |
5-溴-1,3-二氟-2-硝基苯 |
147808-42-2 |
詳細(xì)
|
| Cefcapene Pivoxil Hydrochloride |
鹽酸頭孢卡品酯 |
147816-23-7 |
詳細(xì)
|
| Sitafloxacin Impurity 40 |
SITAFLOXACIN-西他沙星-IMPURITY |
148693-51-0 |
詳細(xì)
|
| Pregabalin Impurity 119 |
Hexanoic acid, 3-[[[3-(aminomethyl)-5-methyl-1-oxohexyl]amino]methyl]-5-methyl- |
1486961-58-3 |
詳細(xì)
|
| Ionone Impurity 11 |
beta-紫羅蘭酮 |
14901-07-6 |
詳細(xì)
|
| Posaconazole Impurity 189 |
1,2-(2,4-二氟苯基)-2-丙烯醇乙酯 |
149809-34-7 |
詳細(xì)
|
| Tigecycline EP Impurity B(9-Aminominocycline) |
替加環(huán)素代謝物M6 |
149934-19-0 |
詳細(xì)
|
| Atomoxetine EP Impurity C |
對甲基阿托西汀鹽酸 |
873310-31-7 |
詳細(xì)
|
| Adrenaline Impurity 26 |
|
|
詳細(xì)
|
| Palonosetron Impurity 12 |
|
|
詳細(xì)
|
| Ticagrelor Impurity 117 |
替格瑞洛雜質(zhì) 117 |
|
詳細(xì)
|
| Brimonidine Impurity 11 |
溴莫尼定雜質(zhì) 3 |
135306-56-8 |
詳細(xì)
|
| Erlotinib Impurity 53 |
Erlotinib Impurity 53 |
749181-30-4 |
詳細(xì)
|
| Sodium Cromoglicate Impurity 5 |
色甘酸鈉雜質(zhì) |
16130-28-2 |
詳細(xì)
|
| Ivabradine USP Rc 1-Oxo Ivabradine |
1616710-52-1 |
1616710-52-1 |
詳細(xì)
|
| Tiotropium Bromide Impurity 33 |
S-托品酸 |
16202-15-6 |
詳細(xì)
|
| Tofacitinib Impurity 166 |
托法替尼雜質(zhì)166 |
1638499-36-1 |
詳細(xì)
|
| Apremilast Impurity C (Apremilast Dimer) |
阿普斯特雜質(zhì)03 |
1802246-60-1 |
詳細(xì)
|
| Ibrutinib Impurity 19 |
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
詳細(xì)
|
| Ticagrelor Impurity 79 |
Ticagrelor Impurity 68 |
1643378-46-4 |
詳細(xì)
|
| Torasemide Impurity 49 |
托拉塞米雜質(zhì)T-1D |
164595-80-6 |
詳細(xì)
|
| Torasemide Impurity 50 |
托拉塞米雜質(zhì)T-1C |
164595-81-7 |
詳細(xì)
|
| Cetirizine EP Impurity G; USP Cetirizine Related Compound G |
4-[(4-氯苯基)苯甲基]-1-哌啶乙醇二鹽酸鹽 |
164726-80-1 |
詳細(xì)
|
| Bromhexine EP Impurity F |
2,4-dibromo-6-((cyclohexylamino)methyl)aniline hydrochloride |
1660957-78-7 |
詳細(xì)
|
| Bromhexine Impurity G |
鹽酸溴已新雜質(zhì)TB |
1660957-96-9 |
詳細(xì)
|
| Cabergoline EP Impurity B |
卡麥角林 EP雜質(zhì) B |
166533-36-4 |
詳細(xì)
|
| Chlorpromazine N-Oxide |
chlorpromazine N-oxide |
1672-76-0 |
詳細(xì)
|
| Mirabegron Impurity 14 |
米拉貝隆雜質(zhì)14 |
1684452-82-1 |
詳細(xì)
|
| Mirabegron Impurity 48 |
米拉貝隆雜質(zhì)17 |
1684452-84-3 |
詳細(xì)
|
| Lenvatinib Impurity L |
4-氨基-3-氯苯酚 |
17609-80-2 |
詳細(xì)
|
| Sofosbuvir Impurity 116 |
索非布韋雜質(zhì)18 |
1627824-09-2 |
詳細(xì)
|
| Tazobactam Impurity 19 |
他唑巴坦酸雜質(zhì)2 |
1628710-72-4 |
詳細(xì)
|
| Calcobutrol |
釓布醇雜質(zhì)21單體 |
1629237-26-8 |
詳細(xì)
|
| Mianserin Impurity 16 |
|
1630-62-2 |
詳細(xì)
|
| Ac-Gln(Trt)-Oh |
AC-N'-三苯甲基-L-谷氨酰胺 |
163277-79-0 |
詳細(xì)
|
| Eldecalcitol Impurity 9 |
2Α-(3-羥丙基)氧基-1Α,25-二羥基維生素D3 |
158689-03-3 |
詳細(xì)
|
| Relugolix Impurity 33 |
2-[(2 ,6-二氟芐基)乙氧基羰基氨基]-4-((二甲基氨基)甲基)-5-(4-硝基苯基)噻吩-3-甲酸乙酯 |
1589503-97-8 |
詳細(xì)
|
| Rapamycin Impurity 11 |
28-O-METHYL-RAPAMYCIN |
159351-88-9 |
詳細(xì)
|
| Selegiline Hydrochloride Impurity 11 |
DL-2-氨基-3-苯基-1-丙醇 |
16088-07-6 |
詳細(xì)
|
| Pregabalin Impurity 145 |
普瑞巴林雜質(zhì)17 |
181289-25-8 |
詳細(xì)
|
| Fmoc-Thr(Tbu)-Thr(Tbu)-Oh |
PSM-TT-1 |
1820578-43-5 |
詳細(xì)
|
| Tofacitinib Related Impurity 10 |
托法替尼雜質(zhì)03 |
1821769-41-8 |
詳細(xì)
|
| Ritonavir Impurity 34 |
Ritonavir Impurity 5 |
183246-46-0 |
詳細(xì)
|
| Erlotinib Hydrochloride Impurity L |
厄洛替尼雜質(zhì)2 |
183320-04-9 |
詳細(xì)
|
| Enzalutamide Impurity 33 |
恩雜魯胺雜質(zhì) |
1839619-50-9 |
詳細(xì)
|
| Azilsartan Impurity 68 |
Azilsartan Impurity 5 |
1857365-17-3 |
詳細(xì)
|
| Lurasidone Impurity 54 |
(3AR,7AR)-4'-(1,2-苯并異噻唑-3-基)八氫螺[2H-異吲哚-2,1'-哌嗪]甲磺酸鹽 |
186204-37-5 |
詳細(xì)
|
| Sitagliptin Impurity 122 |
2-(2,4,5-三氟苯基)乙酰胺 |
1864680-46-5 |
詳細(xì)
|
| Celecoxib Impurity J |
對肼基苯磺酰胺鹽酸鹽 |
17852-52-7 |
詳細(xì)
|
| Agomelatine Impurity 43 |
(E)-(3,4-DIHYDRO-7-METHOXY-1(2H)-NAPHTHALENYLIDENE)ACETONITRILE |
178676-65-8 |
詳細(xì)
|
| Rac-Ruxolitinib-D8 |
RAC-RUXOLITINIB-13C,15N2 |
1794791-38-0 |
詳細(xì)
|
| Clomifene Citrate EP Impurity Gh |
枸櫞酸氯米芬EP雜質(zhì)GH |
1795130-17-4 |
詳細(xì)
|
| Busulfan Impurity 7 |
白消安雜質(zhì)1 |
1797106-48-9 |
詳細(xì)
|
| Isavuconazole Impurity D |
艾沙康唑雜質(zhì) 14 |
1797905-83-9 |
詳細(xì)
|
| Mirabegron Impurity 59 |
米拉貝隆雜質(zhì)59 |
1684452-91-2 |
詳細(xì)
|
| Mirabegron Impurity 29 |
米拉貝隆雜質(zhì)36 |
1684453-05-1 |
詳細(xì)
|
| Peramivir Impurity 61 |
(1S,4R)-4 -(叔丁氧羰基氨基)-環(huán)戊-2-烯基-1-甲酸甲酯 |
168683-02-1 |
詳細(xì)
|
| Mirabegron Impurity 57 |
米拉貝隆雜質(zhì)57 |
168897-09-4 |
詳細(xì)
|
| Tenofovir Impurity 221 |
替諾福韋酯雜質(zhì)10 |
16958-60-4 |
詳細(xì)
|
| Nebivolol Impurity 33 |
奈必洛爾雜質(zhì)46 |
1696472-15-7 |
詳細(xì)
|
| Pantoprazole Chloro Impurity |
泮托拉唑的中間體 |
169905-10-6 |
詳細(xì)
|
| Ketoconazole Impurity 39; Itraconazole Impurity 2 |
酮康唑雜質(zhì)41 |
170210-46-5 |
詳細(xì)
|
| Fmoc-D-Allo-Thr(Tbu)-Oh |
O-(叔丁基)-N-[9H-芴-9-甲氧羰基]-D-別蘇氨酸 |
170643-02-4 |
詳細(xì)
|
| Upadacitinib Impurity 7 |
烏帕替尼雜質(zhì)7 |
1708997-43-6 |
詳細(xì)
|
| Posaconazole Impurity 51 |
2-[(1S,2S)-1-乙基-2-芐氧基丙基]肼甲醛 |
170985-85-0 |
詳細(xì)
|
| Rosuvastatin EP Impurity A (Calcium Salt) |
瑞舒伐他汀鈣EP雜質(zhì)A |
1714147-47-3 |
詳細(xì)
|
| Tadalafil Impurity 16 |
他達(dá)那非中間體 |
171596-41-1 |
詳細(xì)
|
| Abacavir Impurity 8 |
阿巴卡韋雜質(zhì)8 |
171887-01-7 |
詳細(xì)
|
| Butylphthalide Impurity 45 |
丁苯酞雜質(zhì)58 |
172687-90-0 |
詳細(xì)
|
| Paclitaxel Impurity 52; 10-Deacetyl Paclitaxel Ethyl Analogue |
10-脫乙酰紫杉醇乙酯類似物 |
173101-59-2 |
詳細(xì)
|
| Isosorbide Impurity 26 |
異山梨醇雜質(zhì)18 |
175220-76-5 |
詳細(xì)
|
| Pyridoxine Impurity 7 |
維生素B6雜質(zhì)12 |
1805775-66-9 |
詳細(xì)
|
| Atorvastatin EP Impurity C; USP Atorvastatin Related Compound C |
Atorvastatin Impurity 83 |
1807481-00-0 |
詳細(xì)
|
| Folic Acid Impurity 73 |
葉酸雜質(zhì)15 |
153445-05-7 |
詳細(xì)
|
| Empagliflozin Impurity 180 |
恩格列凈雜質(zhì)180 |
15396-36-8 |
詳細(xì)
|
| Tramadol EP Impurity E |
2-(N,N-二甲基氨基甲基)環(huán)己酮 |
15409-60-6 |
詳細(xì)
|
| Vitamin K1 Impurity 95 |
Naphth[2,3-b]oxirene-2,7-dione, 1a,7a-dihydro-1a-methyl- (9CI) |
15448-59-6 |
詳細(xì)
|
| Finerenone Impurity 94 |
非奈利酮中間體(4-氨基-5-甲基-2-甲氧基吡啶) |
1545905-35-8 |
詳細(xì)
|
| Metoprolol EP Impurity O; Metoprolol USP Rc D |
美托洛爾相關(guān)物質(zhì)D |
154784-36-8 |
詳細(xì)
|
| Vancomycin Impurity 21 |
56-亞硝基-萬古霉素 |
155386-25-7 |
詳細(xì)
|
| Atracurium Besilate EP Impurity A |
|
155913-36-3 |
詳細(xì)
|
| Dapoxetine Impurity 13 |
(S)-3-(萘基-1-氧基)-苯丙醇 |
156453-50-8 |
詳細(xì)
|
| Salbutamol EP Impurity J |
沙丁胺醇相關(guān)物質(zhì)B |
156547-62-5 |
詳細(xì)
|
| Ritonavir Impurity 19 |
(2S,3S,5S)-5-氨基-2-(二芐基氨基)-1,6-二苯基己-3-醇 |
156732-15-9 |
詳細(xì)
|
| Cis-Clomiphene (Zuclomiphene) |
珠氯米芬 |
15690-55-8 |
詳細(xì)
|
| Trans-Clomiphene (Enclomiphene) |
恩氯米芬 |
15690-57-0 |
詳細(xì)
|
| Rapamycin Impurity 10 |
西羅莫司雜質(zhì)3 |
157054-84-7 |
詳細(xì)
|
| Amlodipine Impurity 107 |
氨氯地平雜質(zhì)原研代碼0C36-HH |
158151-92-9 |
詳細(xì)
|